MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,444 | -32.8% | 245,655 | -1.2% | 0.00% | – |
| Q2 2023 | $1,141,161 | +92677.3% | 248,619 | 0.0% | 0.00% | – |
| Q1 2023 | $1,230 | -36.6% | 248,619 | -30.0% | 0.00% | -100.0% |
| Q4 2022 | $1,939 | -99.9% | 355,285 | -9.6% | 0.00% | 0.0% |
| Q3 2022 | $2,554,000 | +34.9% | 392,856 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $1,893,000 | -10.3% | 400,231 | +26.5% | 0.00% | 0.0% |
| Q1 2022 | $2,110,000 | -36.2% | 316,371 | -10.0% | 0.00% | 0.0% |
| Q4 2021 | $3,308,000 | +285.5% | 351,388 | +400.3% | 0.00% | – |
| Q3 2021 | $858,000 | – | 70,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |